Types and Treatment of Sandhoff Disease

1492 Words3 Pages

Sandhoff disease is an uncommon hereditary condition that—along with several other disorders—was previously known as amaurotic idiocy. Sandhoff disease destroys nerve cells (neurons) in the brain and spinal cord little by little over time. The disease is described as the buildup of lipid-containing cells in the internal organs and in the nervous system, mental retardation, and loss of sight. It is one of over 50 hereditarily inherited conditions identified as Lysosomal Storage Diseases

The disease was discovered by Konrad Sandhoff (1939- ), a German biologist. Konrad Sadhoff studied the biochemistry of both sphingolipids and gangliosides and in October 1966, he acquired a frozen autopsy substance from a child with amaurotic idiocy. Variances from the Sandhoff disease and his previous cases of Tay-Sachs disease were soon established from his glycolipid analysis. Sandhoff found out that the storage of GA2 was more prominent, in addition to the neuronal storage of GM2 (ganglioside), and dissimilar from all cases of Tay-Sachs disease studied thus far. He also discovered that the globoside amassed in the internal organs and, hexosaminidase activity was almost entirely non-existent. Aside from being the first to give a biochemical description of GM-gangliosides in 1963 and discovering Sandhoff’s disease in 1968, Konrad Sandhoff also discovered several biochemically distinct diseases—namely Tay-Sachs-Disease, the AB-variant of GM2-Gangliosidosis and the B1-variant of GM2-gangliosidosis.

Sandhoff is triggered by the deficiency of two important enzymes: Hexosaminidase A (Hex A) and Hexosaminidase B (Hex B). The most prevalent and critical form of Sandhoff disease becomes obvious in infancy. Infants with this condition characteristically ...

... middle of paper ...

...spiratory infections. The patient must always be under continuous scrutiny since they can undergo aspiration or lack the ability to change from the passageway to their lungs versus their stomach and their spit travels to the lungs which, in turn, causes bronchopneumonia. The patient also does not have the facility to cough and so must undertake a treatment to shake up their body to eliminate the mucus from the lining of their lungs.

At the moment, the government is analyzing a number of treatments including N-butyldeoxynojirimycin in mice, in addition to experimental stem cell treatment in a small number of children using transplants of stem cells from umbilical cord blood and other medical treatments recruiting test patients.

Works Cited

http://en.wikipedia.org/wiki/Sandhoff_disease

http://www.marchofdimes.com/baby/tay-sachs-and-sandhoff-diseases.aspx#

Open Document